Labor Induction. Pregnancy, childbirth and the puerperium
Conditions
Interventions
Vaginal tablets Dinoprostone (Containing 3 mg).
Treatment - Drugs
Vaginal tablets Dinoprostone (Containing 3 mg)
Sponsors
Vice Chancellor for Research and Technology, Babol University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
16 Years to 35 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: women with age 16-35 years, nulligravida, single tone pregnancy, cephalic presentation, Bishop Score equal or less than 5, no contraindication for vaginal delivery, uterine contractions did not start. Exclusion criteria: known allergy to prostaglandins, membrane rupture, fetal infection, history of previous surgery on the uterus and the previous induction of labor in recent pregnancy.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cervix softening. Timepoint: After 12 hours of placing a vaginal suppository. Method of measurement: Bishop score. | — |
Secondary
| Measure | Time frame |
|---|---|
| Duration of the stages of labor. Timepoint: Intervals between each stage (Latent phase, the active phase and second stage of labor). Method of measurement: From time to start feeling regular contractions to dilatation 3-5 cm (Latent phase) / Dilatation from 3-5 cm to complete dilatation (active phase) / Since the complete withdrawal dilatation to fetus (Second stage of labor). | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactNargess Gholizadeh Pasha
Fatemehzahra Fertility & Reproductive Health Reseach Center
Outcome results
None listed